Adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) face a number of burdens, from accessing care to experiencing psychosocial burdens. A team of researchers found that even scheduling appointments can be challenging. These finding... See more
Adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) face a number of burdens, from accessing care to experiencing psychosocial burdens. A team of researchers found that even scheduling appointments can be challenging. These finding... See more
A history of ICI therapy is a strong independent predictor for the development of symptomatic pneumonitis among patients receiving enfortumab vedotin plus pembrolizumab for advanced urothelial carcinoma. Prior treatment with an immune checkpoint inhibitor... See more
Prior treatment with an immune checkpoint inhibitor (ICI) increased the risk of pneumonitis, particularly grade 2 or worse, in patients with locally advanced or metastatic urothelial carcinoma (LA/mUC) undergoing treatment with enfortumab vedotin plus pem... See more
Prophylactic goshajinkigan reduced the incidence of grade 2 or higher chemotherapy-induced peripheral neuropathy in patients receiving carboplatin plus paclitaxel. A traditional Japanese herbal medicine known as goshajinkigan (GJG) has potential for preve... See more
